Review



hdac6 enzymatic activity  (BPS Bioscience)


Bioz Verified Symbol BPS Bioscience is a verified supplier
Bioz Manufacturer Symbol BPS Bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    BPS Bioscience hdac6 enzymatic activity
    ( A ) Ligand-based pharmacophore model derived from a diverse set of known <t>HDAC6</t> inhibitors, highlighting key pharmacophoric features: hydrogen bond donors (green spheres), hydrogen bond acceptors (red spheres), hydrophobic regions (yellow sphere), and ionizable groups (red arrows). ( B ) Receiver Operating Characteristic (ROC) curve generated by automated analysis in LigandScout , demonstrating the model’s ability to discriminate between active and inactive compounds.
    Hdac6 Enzymatic Activity, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 43 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hdac6 enzymatic activity/product/BPS Bioscience
    Average 94 stars, based on 43 article reviews
    hdac6 enzymatic activity - by Bioz Stars, 2026-06
    94/100 stars

    Images

    1) Product Images from "Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma"

    Article Title: Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma

    Journal: Pharmaceuticals

    doi: 10.3390/ph18091303

    ( A ) Ligand-based pharmacophore model derived from a diverse set of known HDAC6 inhibitors, highlighting key pharmacophoric features: hydrogen bond donors (green spheres), hydrogen bond acceptors (red spheres), hydrophobic regions (yellow sphere), and ionizable groups (red arrows). ( B ) Receiver Operating Characteristic (ROC) curve generated by automated analysis in LigandScout , demonstrating the model’s ability to discriminate between active and inactive compounds.
    Figure Legend Snippet: ( A ) Ligand-based pharmacophore model derived from a diverse set of known HDAC6 inhibitors, highlighting key pharmacophoric features: hydrogen bond donors (green spheres), hydrogen bond acceptors (red spheres), hydrophobic regions (yellow sphere), and ionizable groups (red arrows). ( B ) Receiver Operating Characteristic (ROC) curve generated by automated analysis in LigandScout , demonstrating the model’s ability to discriminate between active and inactive compounds.

    Techniques Used: Derivative Assay, Generated

    Workflow of the virtual screening process for discovering novel HDAC6 inhibitors, accompanied by the 2D structures of four selected compounds prioritized for experimental validation.
    Figure Legend Snippet: Workflow of the virtual screening process for discovering novel HDAC6 inhibitors, accompanied by the 2D structures of four selected compounds prioritized for experimental validation.

    Techniques Used: Biomarker Discovery

    Three-dimensional representations of the best docking poses for the four hit compounds selected from the virtual screening. The binding conformations within the HDAC6 active site are shown for: Compound 7 (AKOS030496586), Compound 8 (AKOS000531201), Compound 9 (AKOS030461429) and Compound 10 (AKOS030273637). Ligands are represented as yellow carbon sticks, the protein is depicted as a mauve ribbon, and the catalytic zinc ion is shown as a gray sphere. Key interacting residues are highlighted to illustrate binding interactions.
    Figure Legend Snippet: Three-dimensional representations of the best docking poses for the four hit compounds selected from the virtual screening. The binding conformations within the HDAC6 active site are shown for: Compound 7 (AKOS030496586), Compound 8 (AKOS000531201), Compound 9 (AKOS030461429) and Compound 10 (AKOS030273637). Ligands are represented as yellow carbon sticks, the protein is depicted as a mauve ribbon, and the catalytic zinc ion is shown as a gray sphere. Key interacting residues are highlighted to illustrate binding interactions.

    Techniques Used: Binding Assay

    MDs and MM-GBSA analysis of Compound 8 , Compound 10 , Compound 9 , Compound 7 , and Trichostatin A (used as control) in complex with HDAC6. ( A ) RMSD of ligand heavy atoms over the simulation, expressed in Å; ( B ) Protein-ligand interaction profile showing contacts between ligand atoms and HDAC6 residues. Only interactions occurring for more than 30% of the 200 ns simulation time are displayed; ( C ) Binding free energy profiles calculated using the MM-GBSA method throughout the simulation.
    Figure Legend Snippet: MDs and MM-GBSA analysis of Compound 8 , Compound 10 , Compound 9 , Compound 7 , and Trichostatin A (used as control) in complex with HDAC6. ( A ) RMSD of ligand heavy atoms over the simulation, expressed in Å; ( B ) Protein-ligand interaction profile showing contacts between ligand atoms and HDAC6 residues. Only interactions occurring for more than 30% of the 200 ns simulation time are displayed; ( C ) Binding free energy profiles calculated using the MM-GBSA method throughout the simulation.

    Techniques Used: Control, Binding Assay



    Similar Products

    hdac6 enzymatic activity  (BPS Bioscience)
    94
    BPS Bioscience hdac6 enzymatic activity
    ( A ) Ligand-based pharmacophore model derived from a diverse set of known <t>HDAC6</t> inhibitors, highlighting key pharmacophoric features: hydrogen bond donors (green spheres), hydrogen bond acceptors (red spheres), hydrophobic regions (yellow sphere), and ionizable groups (red arrows). ( B ) Receiver Operating Characteristic (ROC) curve generated by automated analysis in LigandScout , demonstrating the model’s ability to discriminate between active and inactive compounds.
    Hdac6 Enzymatic Activity, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hdac6 enzymatic activity/product/BPS Bioscience
    Average 94 stars, based on 1 article reviews
    hdac6 enzymatic activity - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Ligand-based pharmacophore model derived from a diverse set of known HDAC6 inhibitors, highlighting key pharmacophoric features: hydrogen bond donors (green spheres), hydrogen bond acceptors (red spheres), hydrophobic regions (yellow sphere), and ionizable groups (red arrows). ( B ) Receiver Operating Characteristic (ROC) curve generated by automated analysis in LigandScout , demonstrating the model’s ability to discriminate between active and inactive compounds.

    Journal: Pharmaceuticals

    Article Title: Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma

    doi: 10.3390/ph18091303

    Figure Lengend Snippet: ( A ) Ligand-based pharmacophore model derived from a diverse set of known HDAC6 inhibitors, highlighting key pharmacophoric features: hydrogen bond donors (green spheres), hydrogen bond acceptors (red spheres), hydrophobic regions (yellow sphere), and ionizable groups (red arrows). ( B ) Receiver Operating Characteristic (ROC) curve generated by automated analysis in LigandScout , demonstrating the model’s ability to discriminate between active and inactive compounds.

    Article Snippet: HDAC6 enzymatic activity was assessed using a fluorogenic HDAC6 assay kit (BPS Bioscience, cat#50076, San Diego, CA, USA), which includes a fluorometric substrate containing an acetylated lysine side chain.

    Techniques: Derivative Assay, Generated

    Workflow of the virtual screening process for discovering novel HDAC6 inhibitors, accompanied by the 2D structures of four selected compounds prioritized for experimental validation.

    Journal: Pharmaceuticals

    Article Title: Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma

    doi: 10.3390/ph18091303

    Figure Lengend Snippet: Workflow of the virtual screening process for discovering novel HDAC6 inhibitors, accompanied by the 2D structures of four selected compounds prioritized for experimental validation.

    Article Snippet: HDAC6 enzymatic activity was assessed using a fluorogenic HDAC6 assay kit (BPS Bioscience, cat#50076, San Diego, CA, USA), which includes a fluorometric substrate containing an acetylated lysine side chain.

    Techniques: Biomarker Discovery

    Three-dimensional representations of the best docking poses for the four hit compounds selected from the virtual screening. The binding conformations within the HDAC6 active site are shown for: Compound 7 (AKOS030496586), Compound 8 (AKOS000531201), Compound 9 (AKOS030461429) and Compound 10 (AKOS030273637). Ligands are represented as yellow carbon sticks, the protein is depicted as a mauve ribbon, and the catalytic zinc ion is shown as a gray sphere. Key interacting residues are highlighted to illustrate binding interactions.

    Journal: Pharmaceuticals

    Article Title: Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma

    doi: 10.3390/ph18091303

    Figure Lengend Snippet: Three-dimensional representations of the best docking poses for the four hit compounds selected from the virtual screening. The binding conformations within the HDAC6 active site are shown for: Compound 7 (AKOS030496586), Compound 8 (AKOS000531201), Compound 9 (AKOS030461429) and Compound 10 (AKOS030273637). Ligands are represented as yellow carbon sticks, the protein is depicted as a mauve ribbon, and the catalytic zinc ion is shown as a gray sphere. Key interacting residues are highlighted to illustrate binding interactions.

    Article Snippet: HDAC6 enzymatic activity was assessed using a fluorogenic HDAC6 assay kit (BPS Bioscience, cat#50076, San Diego, CA, USA), which includes a fluorometric substrate containing an acetylated lysine side chain.

    Techniques: Binding Assay

    MDs and MM-GBSA analysis of Compound 8 , Compound 10 , Compound 9 , Compound 7 , and Trichostatin A (used as control) in complex with HDAC6. ( A ) RMSD of ligand heavy atoms over the simulation, expressed in Å; ( B ) Protein-ligand interaction profile showing contacts between ligand atoms and HDAC6 residues. Only interactions occurring for more than 30% of the 200 ns simulation time are displayed; ( C ) Binding free energy profiles calculated using the MM-GBSA method throughout the simulation.

    Journal: Pharmaceuticals

    Article Title: Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma

    doi: 10.3390/ph18091303

    Figure Lengend Snippet: MDs and MM-GBSA analysis of Compound 8 , Compound 10 , Compound 9 , Compound 7 , and Trichostatin A (used as control) in complex with HDAC6. ( A ) RMSD of ligand heavy atoms over the simulation, expressed in Å; ( B ) Protein-ligand interaction profile showing contacts between ligand atoms and HDAC6 residues. Only interactions occurring for more than 30% of the 200 ns simulation time are displayed; ( C ) Binding free energy profiles calculated using the MM-GBSA method throughout the simulation.

    Article Snippet: HDAC6 enzymatic activity was assessed using a fluorogenic HDAC6 assay kit (BPS Bioscience, cat#50076, San Diego, CA, USA), which includes a fluorometric substrate containing an acetylated lysine side chain.

    Techniques: Control, Binding Assay